Abbott Laboratories said its third-quarter profit jumped 51 percent, led by sales of the arthritis medication Humira and increase in sales of stents and other heart-related devices.
Abbott Laboratories said its third-quarter profit jumped 51 percent, led by sales of the arthritis medication Humira and increase in sales of stents and other heart-related devices.